Mauritania has observed a 16% (228.6%) increase in the pregnant women living with hiv antiretroviral therapy coverage for pmtct, which now stands at 23%.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Mauritania
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Mauritania
PMTCT antiretroviral therapy coverage
More indicators for Mauritania
Male unintentional poisoning
1.7
0.0
(2019)
Female wasting in children
8.4%
+2.6%
(2021)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar80
-intl dollar3
(2021)
Birth registration
44.8%
-20.8%
(2021)
Contraceptive modern method prevalence
12.8%
+2.8%
(2021)
Mauritania PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 23% | +16% |
| 2021 | 7% | -13% |
| 2020 | 20% | -15% |
| 2019 | 35% | +16% |
| 2018 | 19% | +7% |
| 2017 | 12% | -5% |
| 2016 | 17% | -37% |
| 2015 | 54% | -4% |
| 2014 | 58% | +49% |
| 2013 | 9% | +5% |
| 2012 | 4% | -5% |
| 2011 | 9% | +1% |
| 2010 | 8% | 0% |
| 2009 | 8% | +3% |
| 2008 | 5% | -2% |
| 2007 | 7% | +6% |
| 2006 | 1% | +1% |
| 2005 | 0% | 0% |
| 2004 | 0% | 0% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |